Trevi Therapeutics (TRVI) Shares Issued (2018 - 2026)
Trevi Therapeutics' quarterly Shares Issued came in at $222000.0 in Q1 2026, down 97.3% year-on-year from $8.2 million in Q1 2025, and down 89.01% quarter-over-quarter from $2.0 million in Q4 2025.
Trevi Therapeutics has reported Shares Issued for 9 years, with the latest figure at $222000.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued fell 97.3% year-over-year to $222000.0; the trailing twelve-month figure through Mar 2026 stood at -$5.9 million (down 168.75% YoY), and the FY2025 full-year result was $2.1 million, up 427.66% from the prior year.
- Shares Issued for Q1 2026 stood at $222000.0, down from $2.0 million in the prior quarter.
- The five-year high for Shares Issued was $11.8 million in Q4 2022, with the low at -$7.5 million in Q2 2025.
- Average Shares Issued over 5 years is $969666.7, with a median of $21000.0 recorded in 2022.
- Peak annual rise in Shares Issued reached 205400.0% in 2025, while the deepest fall reached 187125.0% in 2025.
- Tracing TRVI's Shares Issued over 5 years: stood at $11.8 million in 2022, then slumped by 100.04% to -$5000.0 in 2023, then surged by 7980.0% to $394000.0 in 2024, then jumped by 412.69% to $2.0 million in 2025, then slumped by 89.01% to $222000.0 in 2026.
- The last three Shares Issued figures came in at $222000.0 (Q1 2026), $2.0 million (Q4 2025), and -$672000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | 222,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 222,000.00 |
| Mar 31, 2026 | 222,000.00 |
| Dec 31, 2025 | 2.02 Mn |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | -672,000.00 |
| Sep 30, 2025 | -672,000.00 |
| Jun 30, 2025 | -7.49 Mn |
| Jun 30, 2025 | -7.49 Mn |
| Mar 31, 2025 | 8.22 Mn |
| Mar 31, 2025 | 8.22 Mn |
| Dec 31, 2024 | 394,000.00 |
| Dec 31, 2024 | 394,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | -5,000.00 |
| Dec 31, 2023 | -5,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | -29,000.00 |
| Jun 30, 2023 | -29,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Dec 31, 2022 | 11.76 Mn |
| Dec 31, 2022 | 11.76 Mn |
| Jun 30, 2022 | 21,000.00 |
| Jun 30, 2022 | 21,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | -14,000.00 |
| Dec 31, 2021 | -14,000.00 |
| Dec 31, 2020 | -22,000.00 |
| Dec 31, 2020 | -22,000.00 |
| Sep 30, 2020 | 7,000.00 |
| Sep 30, 2020 | 7,000.00 |
| Sep 30, 2019 | 37.20 Mn |
| Sep 30, 2019 | 37.20 Mn |
| Jun 30, 2019 | 13.93 Mn |
| Jun 30, 2019 | 13.93 Mn |
| Mar 31, 2019 | 24,000.00 |
| Mar 31, 2019 | 24,000.00 |
| Mar 31, 2018 | 13,000.00 |
| Mar 31, 2018 | 13,000.00 |